• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过敏降低脑膜瘤风险:荟萃分析。

Allergy reduces the risk of meningioma: a meta-analysis.

机构信息

Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, China.

Department of Interventional Neuroradiology, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

出版信息

Sci Rep. 2017 Jan 10;7:40333. doi: 10.1038/srep40333.

DOI:10.1038/srep40333
PMID:28071746
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5223136/
Abstract

Meningiomas are the most common brain tumours; however, little is known regarding their aetiology. The data are inconsistent concerning atopic disease and the risk of developing meningioma. Thus, we conducted a meta-analysis to investigate the association between allergic conditions and the risk of developing meningioma. A systematic literature search was conducted using PubMed and Web of SCI from Jan 1979 to Feb 2016. Two investigators independently selected the relevant articles according to the inclusion criteria. Eight case-control studies and 2 cohort studies were included in the final analysis, comprising 5,679 meningioma cases and 55,621 control subjects. Compared with no history of allergy, the pooled odds ratio (OR) for allergic conditions was 0.81 (0.70-0.94) for meningioma in a random-effects meta-analysis. Inverse correlations of meningioma occurrence were also identified for asthma and eczema, in which the pooled ORs were 0.78 (0.70-0.86) and 0.78 (0.69-0.87), respectively. A reduced risk of meningioma occurrence was identified in hay fever; however, the association was weak (0.88, 95% CI = 0.78-0.99). The source of this heterogeneity could be the various confounding variables in individual studies. Overall, the current meta-analysis indicated that allergy reduced the risk of developing meningiomas. Large cohort studies are required to investigate this relationship.

摘要

脑膜瘤是最常见的脑肿瘤;然而,关于其病因知之甚少。特应性疾病与脑膜瘤发病风险之间的数据并不一致。因此,我们进行了一项荟萃分析,以调查过敏与脑膜瘤发病风险之间的关系。使用 PubMed 和 Web of SCI 从 1979 年 1 月至 2016 年 2 月进行了系统的文献检索。两名调查员根据纳入标准独立选择了相关文章。最终分析包括 8 项病例对照研究和 2 项队列研究,共包含 5679 例脑膜瘤病例和 55621 例对照。与无过敏史相比,过敏性疾病的汇总比值比(OR)为 0.81(0.70-0.94)。在随机效应荟萃分析中,哮喘和湿疹也与脑膜瘤发生呈负相关,汇总 OR 分别为 0.78(0.70-0.86)和 0.78(0.69-0.87)。花粉症与脑膜瘤发生的风险降低相关,但相关性较弱(0.88,95%CI=0.78-0.99)。这种异质性的来源可能是个别研究中的各种混杂变量。总体而言,目前的荟萃分析表明过敏降低了发生脑膜瘤的风险。需要进行大型队列研究来进一步调查这种关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaee/5223136/7ab8e3f31051/srep40333-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaee/5223136/a430b0d89bf1/srep40333-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaee/5223136/7ab8e3f31051/srep40333-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaee/5223136/a430b0d89bf1/srep40333-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaee/5223136/7ab8e3f31051/srep40333-f2.jpg

相似文献

1
Allergy reduces the risk of meningioma: a meta-analysis.过敏降低脑膜瘤风险:荟萃分析。
Sci Rep. 2017 Jan 10;7:40333. doi: 10.1038/srep40333.
2
Inverse association between eczema and meningioma: a meta-analysis.湿疹与脑膜瘤呈负相关:一项荟萃分析。
Cancer Causes Control. 2011 Oct;22(10):1355-63. doi: 10.1007/s10552-011-9808-6. Epub 2011 Jun 28.
3
Atopy and risk of brain tumors: a meta-analysis.特应性与脑肿瘤风险:一项荟萃分析。
J Natl Cancer Inst. 2007 Oct 17;99(20):1544-50. doi: 10.1093/jnci/djm170. Epub 2007 Oct 9.
4
Allergic conditions and risk of glioma and meningioma in the CERENAT case-control study.过敏性疾病与 CERENAT 病例对照研究中神经胶质瘤和脑膜瘤的风险。
J Neurooncol. 2018 Jun;138(2):271-281. doi: 10.1007/s11060-018-2816-6. Epub 2018 Mar 2.
5
Allergy and risk of glioma: a meta-analysis.过敏与脑胶质瘤风险:荟萃分析。
Eur J Neurol. 2011 Mar;18(3):387-95. doi: 10.1111/j.1468-1331.2010.03187.x. Epub 2010 Aug 16.
6
Allergic conditions and brain tumor risk.过敏状况与脑肿瘤风险。
Am J Epidemiol. 2007 Oct 15;166(8):941-50. doi: 10.1093/aje/kwm203. Epub 2007 Jul 23.
7
History of allergic disease and risk of meningioma.过敏性疾病史与脑膜瘤风险
Am J Epidemiol. 2007 Mar 1;165(5):477-85. doi: 10.1093/aje/kwk048. Epub 2006 Dec 20.
8
Association of allergic diseases and epilepsy with risk of glioma, meningioma and acoustic neuroma: results from the INTERPHONE international case-control study.过敏性疾病和癫痫与脑胶质瘤、脑膜瘤和听神经瘤风险的相关性:来自 INTERPHONE 国际病例对照研究的结果。
Eur J Epidemiol. 2022 May;37(5):503-512. doi: 10.1007/s10654-022-00843-y. Epub 2022 Feb 3.
9
History of allergic disease and epilepsy and risk of glioma and meningioma (INTERPHONE study group, Germany).过敏性疾病和癫痫病史与胶质瘤和脑膜瘤风险(德国INTERPHONE研究组)
Eur J Epidemiol. 2009;24(8):433-40. doi: 10.1007/s10654-009-9355-6. Epub 2009 May 31.
10
Allergy and brain tumors in the INTERPHONE study: pooled results from Australia, Canada, France, Israel, and New Zealand.INTERPHONE 研究中的过敏和脑肿瘤:来自澳大利亚、加拿大、法国、以色列和新西兰的汇总结果。
Cancer Causes Control. 2013 May;24(5):949-60. doi: 10.1007/s10552-013-0171-7. Epub 2013 Feb 27.

引用本文的文献

1
Maternal and Perinatal Factors Associated With Childhood Brain Tumors: A Case-Control Study in Vietnam.与儿童脑肿瘤相关的母体和围产期因素:越南的病例对照研究。
Cancer Control. 2024 Jan-Dec;31:10732748241258602. doi: 10.1177/10732748241258602.
2
Meningioma: A Review of Epidemiology, Pathology, Diagnosis, Treatment, and Future Directions.脑膜瘤:流行病学、病理学、诊断、治疗及未来方向综述
Biomedicines. 2021 Mar 21;9(3):319. doi: 10.3390/biomedicines9030319.
3
Intracranial tumors of the central nervous system and air pollution - a nationwide case-control study from Denmark.

本文引用的文献

1
Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study.关于过敏与胶质瘤风险之间关联达成科学共识:来自胶质瘤国际病例对照研究的报告
Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):282-90. doi: 10.1158/1055-9965.EPI-15-0847.
2
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.CBTRUS统计报告:2008 - 2012年美国原发性脑和中枢神经系统肿瘤诊断情况
Neuro Oncol. 2015 Oct;17 Suppl 4(Suppl 4):iv1-iv62. doi: 10.1093/neuonc/nov189. Epub 2015 Oct 27.
3
Body mass index, physical activity, and risk of adult meningioma and glioma: A meta-analysis.
中枢神经系统颅内肿瘤与空气污染——来自丹麦的全国性病例对照研究。
Environ Health. 2020 Jul 8;19(1):81. doi: 10.1186/s12940-020-00631-9.
4
Allergic conditions and risk of glioma and meningioma in the CERENAT case-control study.过敏性疾病与 CERENAT 病例对照研究中神经胶质瘤和脑膜瘤的风险。
J Neurooncol. 2018 Jun;138(2):271-281. doi: 10.1007/s11060-018-2816-6. Epub 2018 Mar 2.
体重指数、身体活动与成人脑膜瘤和胶质瘤风险:一项荟萃分析。
Neurology. 2015 Oct 13;85(15):1342-50. doi: 10.1212/WNL.0000000000002020. Epub 2015 Sep 16.
4
Tumor infiltrating immune cells in gliomas and meningiomas.脑胶质瘤和脑膜瘤中的肿瘤浸润免疫细胞。
Brain Behav Immun. 2016 Mar;53:1-15. doi: 10.1016/j.bbi.2015.07.019. Epub 2015 Jul 26.
5
Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma.间变性脑膜瘤中免疫调节分子PD-L1(CD274)表达增加。
Oncotarget. 2015 Mar 10;6(7):4704-16. doi: 10.18632/oncotarget.3082.
6
IgE-based immunotherapy of cancer: challenges and chances.基于 IgE 的癌症免疫疗法:挑战与机遇。
Allergy. 2014 Feb;69(2):137-49. doi: 10.1111/all.12276. Epub 2013 Oct 14.
7
Nonallergic comorbidities of atopic eczema: an overview of systematic reviews.特应性皮炎的非过敏性共病:系统评价概述。
Allergy. 2014 Jan;69(1):37-45. doi: 10.1111/all.12246. Epub 2013 Sep 21.
8
Allergy and brain tumors in the INTERPHONE study: pooled results from Australia, Canada, France, Israel, and New Zealand.INTERPHONE 研究中的过敏和脑肿瘤:来自澳大利亚、加拿大、法国、以色列和新西兰的汇总结果。
Cancer Causes Control. 2013 May;24(5):949-60. doi: 10.1007/s10552-013-0171-7. Epub 2013 Feb 27.
9
Impaired survival and long-term neurological problems in benign meningioma.良性脑膜瘤患者的生存率降低和长期神经问题。
Neuro Oncol. 2012 May;14(5):658-66. doi: 10.1093/neuonc/nos013. Epub 2012 Mar 9.
10
Recombinant IgE antibodies for passive immunotherapy of solid tumours: from concept towards clinical application.用于实体瘤被动免疫治疗的重组 IgE 抗体:从概念到临床应用。
Cancer Immunol Immunother. 2012 Sep;61(9):1547-64. doi: 10.1007/s00262-011-1162-8. Epub 2011 Dec 3.